CorMedix (CRMD) Operating Margin (2016 - 2025)
Historic Operating Margin for CorMedix (CRMD) over the last 14 years, with Q3 2025 value amounting to 49.24%.
- CorMedix's Operating Margin rose 779400.0% to 49.24% in Q3 2025 from the same period last year, while for Sep 2025 it was 48.51%, marking a year-over-year increase of 4223800.0%. This contributed to the annual value of 51.43% for FY2024, which is 1428021500.0% down from last year.
- Per CorMedix's latest filing, its Operating Margin stood at 49.24% for Q3 2025, which was up 779400.0% from 49.18% recorded in Q2 2025.
- CorMedix's Operating Margin's 5-year high stood at 201753.24% during Q2 2023, with a 5-year trough of 102126.07% in Q3 2022.
- Its 5-year average for Operating Margin is 10984.46%, with a median of 963.39% in 2024.
- Per our database at Business Quant, CorMedix's Operating Margin soared by 2000000000bps in 2023 and then tumbled by 2000000000bps in 2024.
- CorMedix's Operating Margin (Quarter) stood at 13794.92% in 2021, then plummeted by -105bps to 28244.66% in 2022, then soared by 383bps to 79823.71% in 2023, then plummeted by -100bps to 41.45% in 2024, then grew by 19bps to 49.24% in 2025.
- Its Operating Margin was 49.24% in Q3 2025, compared to 49.18% in Q2 2025 and 51.5% in Q1 2025.